Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study.

Stegemann C, Pechlaner R, Willeit P, Langley SR, Mangino M, Mayr U, Menni C, Moayyeri A, Santer P, Rungger G, Spector TD, Willeit J, Kiechl S, Mayr M.

Circulation. 2014 May 6;129(18):1821-31. doi: 10.1161/CIRCULATIONAHA.113.002500. Epub 2014 Mar 12.

2.

Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts.

Würtz P, Havulinna AS, Soininen P, Tynkkynen T, Prieto-Merino D, Tillin T, Ghorbani A, Artati A, Wang Q, Tiainen M, Kangas AJ, Kettunen J, Kaikkonen J, Mikkilä V, Jula A, Kähönen M, Lehtimäki T, Lawlor DA, Gaunt TR, Hughes AD, Sattar N, Illig T, Adamski J, Wang TJ, Perola M, Ripatti S, Vasan RS, Raitakari OT, Gerszten RE, Casas JP, Chaturvedi N, Ala-Korpela M, Salomaa V.

Circulation. 2015 Mar 3;131(9):774-85. doi: 10.1161/CIRCULATIONAHA.114.013116. Epub 2015 Jan 8.

3.

Plasma Lipidomic Profiles Improve on Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes Mellitus.

Alshehry ZH, Mundra PA, Barlow CK, Mellett NA, Wong G, McConville MJ, Simes J, Tonkin AM, Sullivan DR, Barnes EH, Nestel PJ, Kingwell BA, Marre M, Neal B, Poulter NR, Rodgers A, Williams B, Zoungas S, Hillis GS, Chalmers J, Woodward M, Meikle PJ.

Circulation. 2016 Nov 22;134(21):1637-1650. Epub 2016 Oct 18.

4.

Seeking a unique lipid signature predicting cardiovascular disease risk.

Brown JM, Hazen SL.

Circulation. 2014 May 6;129(18):1799-803. doi: 10.1161/CIRCULATIONAHA.114.009224. Epub 2014 Mar 12. No abstract available.

5.

Metabolomics Reveals Altered Lipid Metabolism in a Mouse Model of Endometriosis.

Dutta M, Anitha M, Smith PB, Chiaro CR, Maan M, Chaudhury K, Patterson AD.

J Proteome Res. 2016 Aug 5;15(8):2626-33. doi: 10.1021/acs.jproteome.6b00197. Epub 2016 Jul 5.

PMID:
27246581
6.

Lipidomics: quest for molecular lipid biomarkers in cardiovascular disease.

Hinterwirth H, Stegemann C, Mayr M.

Circ Cardiovasc Genet. 2014 Dec;7(6):941-54. doi: 10.1161/CIRCGENETICS.114.000550.

7.

Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease.

Shah SH, Sun JL, Stevens RD, Bain JR, Muehlbauer MJ, Pieper KS, Haynes C, Hauser ER, Kraus WE, Granger CB, Newgard CB, Califf RM, Newby LK.

Am Heart J. 2012 May;163(5):844-850.e1. doi: 10.1016/j.ahj.2012.02.005.

PMID:
22607863
8.

Very-Low-Density Lipoprotein-Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III.

Pechlaner R, Tsimikas S, Yin X, Willeit P, Baig F, Santer P, Oberhollenzer F, Egger G, Witztum JL, Alexander VJ, Willeit J, Kiechl S, Mayr M.

J Am Coll Cardiol. 2017 Feb 21;69(7):789-800. doi: 10.1016/j.jacc.2016.11.065.

9.

Lipidomics applications for discovering biomarkers of diseases in clinical chemistry.

Zhao YY, Cheng XL, Lin RC.

Int Rev Cell Mol Biol. 2014;313:1-26. doi: 10.1016/B978-0-12-800177-6.00001-3. Review.

PMID:
25376488
10.

Top-down lipidomics of low density lipoprotein reveal altered lipid profiles in advanced chronic kidney disease.

Reis A, Rudnitskaya A, Chariyavilaskul P, Dhaun N, Melville V, Goddard J, Webb DJ, Pitt AR, Spickett CM.

J Lipid Res. 2015 Feb;56(2):413-22. doi: 10.1194/jlr.M055624. Epub 2014 Nov 25.

11.

Large-scale metabolomic profiling identifies novel biomarkers for incident coronary heart disease.

Ganna A, Salihovic S, Sundström J, Broeckling CD, Hedman AK, Magnusson PK, Pedersen NL, Larsson A, Siegbahn A, Zilmer M, Prenni J, Arnlöv J, Lind L, Fall T, Ingelsson E.

PLoS Genet. 2014 Dec 11;10(12):e1004801. doi: 10.1371/journal.pgen.1004801. eCollection 2014 Dec.

12.

Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics.

Han X, Rozen S, Boyle SH, Hellegers C, Cheng H, Burke JR, Welsh-Bohmer KA, Doraiswamy PM, Kaddurah-Daouk R.

PLoS One. 2011;6(7):e21643. doi: 10.1371/journal.pone.0021643. Epub 2011 Jul 11.

13.

The prediction of type 2 diabetes in women with previous gestational diabetes mellitus using lipidomics.

Lappas M, Mundra PA, Wong G, Huynh K, Jinks D, Georgiou HM, Permezel M, Meikle PJ.

Diabetologia. 2015 Jul;58(7):1436-42. doi: 10.1007/s00125-015-3587-7. Epub 2015 Apr 17.

PMID:
25893729
14.

A plasma long-chain acylcarnitine predicts cardiovascular mortality in incident dialysis patients.

Kalim S, Clish CB, Wenger J, Elmariah S, Yeh RW, Deferio JJ, Pierce K, Deik A, Gerszten RE, Thadhani R, Rhee EP.

J Am Heart Assoc. 2013 Dec 5;2(6):e000542. doi: 10.1161/JAHA.113.000542.

15.

Lipids of human myocardium.

Fletcher RF.

Lipids. 1972 Nov;7(11):728-32. No abstract available.

PMID:
4634549
16.

Lipidome as a predictive tool in progression to type 2 diabetes in Finnish men.

Suvitaival T, Bondia-Pons I, Yetukuri L, Pöhö P, Nolan JJ, Hyötyläinen T, Kuusisto J, Orešič M.

Metabolism. 2018 Jan;78:1-12. doi: 10.1016/j.metabol.2017.08.014. Epub 2017 Sep 20.

17.

Cardiovascular Risk Factors Associated With Blood Metabolite Concentrations and Their Alterations During a 4-Year Period in a Population-Based Cohort.

Lacruz ME, Kluttig A, Tiller D, Medenwald D, Giegling I, Rujescu D, Prehn C, Adamski J, Frantz S, Greiser KH, Emeny RT, Kastenmüller G, Haerting J.

Circ Cardiovasc Genet. 2016 Dec;9(6):487-494. doi: 10.1161/CIRCGENETICS.116.001444. Epub 2016 Oct 26.

18.

Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans.

Rhee EP, Cheng S, Larson MG, Walford GA, Lewis GD, McCabe E, Yang E, Farrell L, Fox CS, O'Donnell CJ, Carr SA, Vasan RS, Florez JC, Clish CB, Wang TJ, Gerszten RE.

J Clin Invest. 2011 Apr;121(4):1402-11. doi: 10.1172/JCI44442. Epub 2011 Mar 14.

19.

[Incorporation in vivo of 1-14C-azelaic acid into rat lipids].

Dousset N, Douste-Blazy L.

C R Acad Sci Hebd Seances Acad Sci D. 1969 Nov 24;269(21):2144-6. French. No abstract available.

PMID:
4983513
20.

C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men.

Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR.

Circulation. 2008 Nov 25;118(22):2243-51, 4p following 2251. doi: 10.1161/CIRCULATIONAHA.108.814251. Epub 2008 Nov 9.

Supplemental Content

Support Center